Key Considerations for Reducing PGx Testing Costs

This article presents an expert guide focused on reducing costs associated with pharmacogenomics (PGx) testing. Dr. Vicky Pratt outlines five key considerations that laboratories can implement to create a cost-effective PGx testing program while ensuring quality and efficiency. The document details the challenges that often lead to unexpectedly high testing costs and suggests practical strategies to mitigate these expenses. Among the recommendations are employing a targeted approach to testing, eliminating the need for multiple replicates per sample, minimizing reagent waste, consolidating workflows, and avoiding multiple assays for copy number calling. Each strategy is designed to help laboratories maintain accuracy and breadth of genetic information while significantly reducing overall costs. The insights provided are based on Dr. Pratt's extensive experience in the field and aim to guide laboratories in establishing economically viable PGx testing programs.